Edwards Lifesciences vs IDEXX Laboratories
Edwards Lifesciences (EW), health care, and IDEXX Laboratories (IDXX), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Edwards Lifesciences is worth $61.8B on the stock market and IDEXX Laboratories $54.8B: Edwards Lifesciences is valued at 13% more. Edwards Lifesciences trades at 62.5 times earnings and IDEXX Laboratories at 46.8; operating margins in their latest fiscal years were 20.8% and 31.6%. Over the past year Edwards Lifesciences's share price has moved +27.5% and IDEXX Laboratories's +4.54%.
Key facts
- Edwards Lifesciences market value
- $61.8B
- IDEXX Laboratories market value
- $54.8B
- Edwards Lifesciences P/E
- 62.5
- IDEXX Laboratories P/E
- 46.8
- Edwards Lifesciences revenue
- $6.1BFY to 2025-12-31
- IDEXX Laboratories revenue
- $4.3BFY to 2025-12-31
- Superinvestors holding both
- 4
Market values as of .
| Measure | Edwards Lifesciences | IDEXX Laboratories |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $61.8Bhigher | $54.8Blower |
| Revenue | $6.1Bhigher | $4.3Blower |
| Earnings | $1.1Bhigher | $1.1Blower |
| Employees | 16,000higher | 11,000lower |
| Total assets | $13.7Bhigher | $3.4Blower |
| Valuation | ||
| P/E | 62.5higher | 46.8lower |
| P/S | 10.2lower | 12.7higher |
| P/B | 5.7lower | 29.3higher |
| Dividend yield | 0.00% | 0.00% |
| Profitability | ||
| Operating margin | 20.8%lower | 31.6%higher |
| Balance sheet | ||
| Net assets | $10.3Bhigher | $1.6Blower |
| Total liabilities | $3.4Bhigher | $1.7Blower |
| Total debt | $598.3Mhigher | $450Mlower |
| Cash on hand | $2.9Bhigher | $180.1Mlower |
| Price change | ||
| Today | +0.29%higher | -0.82%lower |
| 1 year | +27.5%higher | +4.54%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (4)
- Brandon Haley0.7% / 0.2%
- Steve Cohen0.2% / 0.2%
- Baillie Gifford team0.1% / 0.1%
- Ron Baron0.1% / 1.6%
Edwards Lifesciences only (5)
- David Rolfe3.1%
- Howard Gleicher1.6%
- Israel Englander0.2%
- Ken Griffin0.2%
- Primecap team0.2%
IDEXX Laboratories only (6)
- Terry Smith2.9%
- Polen Capital team2.2%
- Jensen team1.8%
- Wallace Weitz1.3%
- Mairs & Power team<0.1%
- Bill Nygren<0.1%
Percentages are each holding's share of that investor's reported portfolio (under "Both": Edwards Lifesciences / IDEXX Laboratories). Who owns EW · Who owns IDXX
More on Edwards Lifesciences
Further comparisons
Edwards Lifesciences against its closest peers
IDEXX Laboratories against its closest peers
Learn
Questions and answers
Which is bigger, Edwards Lifesciences or IDEXX Laboratories?
By market value, Edwards Lifesciences is the larger: $61.8B against $54.8B for IDEXX Laboratories. By revenue in its latest fiscal year, Edwards Lifesciences is the larger: $6.1B against $4.3B for IDEXX Laboratories.
Which has the higher P/E ratio?
Edwards Lifesciences: 62.5, against 46.8 for IDEXX Laboratories. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
IDEXX Laboratories: 31.6%, against 20.8% for Edwards Lifesciences. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has the higher dividend yield?
Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
Edwards Lifesciences: $598.3M, against $450M for IDEXX Laboratories. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Edwards Lifesciences and IDEXX Laboratories?
In their latest 13F filings, Brandon Haley, Steve Cohen, Baillie Gifford team and Ron Baron hold both.
Cite this page
Funkfolio, “Edwards Lifesciences vs IDEXX Laboratories”, data as of 17 November 2026. https://funkfolio.com/compare/ew-vs-idxx
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.